Bafna Pharmaceuticals Limited (BAFNAPH) — Capital Reinvestment Ratio
Bafna Pharmaceuticals Limited (BAFNAPH) has a Capital Reinvestment Ratio of 1.76x as of September 2025, meaning it reinvests 2% of its operating cash flow (Rs93.12 Million) in capital expenditures (Rs164.17 Million). See net asset quality index of Bafna Pharmaceuticals Limited to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Bafna Pharmaceuticals Limited Capital Reinvestment Ratio (2007–2025)
This chart tracks Bafna Pharmaceuticals Limited's Capital Reinvestment Ratio across 9 annual periods. Check Bafna Pharmaceuticals Limited (BAFNAPH) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Bafna Pharmaceuticals Limited (2007–2025)
Year-by-year Capital Reinvestment Ratio for Bafna Pharmaceuticals Limited from 2007 to 2025. For live market cap and broader valuation context, see Bafna Pharmaceuticals Limited stock valuation.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.12x | Rs195.29 Million | Rs218.60 Million | ▼ -31.8% |
| 2024 | 1.64x | Rs94.85 Million | Rs155.78 Million | ▼ -1.0% |
| 2023 | 1.66x | Rs49.52 Million | Rs82.19 Million | ▲ +114.1% |
| 2022 | 0.78x | Rs97.28 Million | Rs75.41 Million | ▼ -69.4% |
| 2016 | 2.53x | Rs9.11 Million | Rs23.07 Million | ▲ +246.7% |
| 2015 | 0.73x | Rs106.65 Million | Rs77.90 Million | ▼ -33.1% |
| 2014 | 1.09x | Rs16.06 Million | Rs17.53 Million | ▲ +1778.7% |
| 2013 | 0.06x | Rs366.32 Million | Rs21.28 Million | ▼ -96.9% |
| 2007 | 1.85x | Rs101.06 Million | Rs187.01 Million | — |